Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Item TypeItem Type
-
SubjectSubject
-
YearFrom:-To:
-
More FiltersMore FiltersSourceLanguage
Done
Filters
Reset
7
result(s) for
"Shapiro, M.C."
Sort by:
Evidence for a nematic component to the hidden-order parameter in URu2Si2 from differential elastoresistance measurements
by
Wartenbe, Mark
,
Shapiro, M.C.
,
Giraldo-Gallo, P.
in
639/301/119/995
,
639/766/119/2795
,
Anisotropy
2015
For materials that harbour a continuous phase transition, the susceptibility of the material to various fields can be used to understand the nature of the fluctuating order and hence the nature of the ordered state. Here we use anisotropic biaxial strain to probe the nematic susceptibility of URu
2
Si
2
, a heavy fermion material for which the nature of the low temperature ‘hidden order’ state has defied comprehensive understanding for over 30 years. Our measurements reveal that the fluctuating order has a nematic component, confirming reports of twofold anisotropy in the broken symmetry state and strongly constraining theoretical models of the hidden-order phase.
The heavy fermion material URu
2
Si
2
exhibits a hidden-order phase transition that remains poorly understood. Using differential elastoresistance measurements, Riggs
et al
. show that this phase has a nematic component and that it spontaneously breaks fourfold lattice symmetry.
Journal Article
High molecular gas fractions in normal massive star-forming galaxies in the young Universe
2010
Gas supply to the stars
Star formation requires the presence of cold molecular gas, which makes up only a small fraction of the total mass of the Milky Way and nearby galaxies where only a few new stars are formed per year. To establish whether the rapid star formation occurring in distant massive galaxies reflects a greater supply of cold gas or a more efficient process of star formation, gas content was surveyed in massive-star-forming galaxies at two cosmic epochs — at redshifts of approximately 1.2 and 2.3, when the Universe was 40% and 24% of its current age. The results reveal that distant star-forming galaxies were indeed gas rich and that the star-formation efficiency is not strongly dependent on cosmic epoch. The average fraction of cold gas relative to total galaxy mass is three to ten times higher in distant galaxies than in today's massive spiral galaxies.
Stars form from cold molecular interstellar gas, which is relatively rare in the local Universe, such that galaxies like the Milky Way form only a few new stars per year. However, typical massive galaxies in the distant Universe formed stars much more rapidly, suggesting that young galaxies were more rich in molecular gas. The results of a survey of molecular gas in samples of typical massive star-forming galaxies when the Universe was 40% and 24% of its current age now reveal that distant star-forming galaxies were indeed gas rich.
Stars form from cold molecular interstellar gas. As this is relatively rare in the local Universe, galaxies like the Milky Way form only a few new stars per year. Typical massive galaxies in the distant Universe formed stars an order of magnitude more rapidly
1
,
2
. Unless star formation was significantly more efficient, this difference suggests that young galaxies were much more molecular-gas rich. Molecular gas observations in the distant Universe have so far largely been restricted to very luminous, rare objects, including mergers and quasars
3
,
4
,
5
, and accordingly we do not yet have a clear idea about the gas content of more normal (albeit massive) galaxies. Here we report the results of a survey of molecular gas in samples of typical massive-star-forming galaxies at mean redshifts <
z
> of about 1.2 and 2.3, when the Universe was respectively 40% and 24% of its current age. Our measurements reveal that distant star forming galaxies were indeed gas rich, and that the star formation efficiency is not strongly dependent on cosmic epoch. The average fraction of cold gas relative to total galaxy baryonic mass at
z
= 2.3 and
z
= 1.2 is respectively about 44% and 34%, three to ten times higher than in today’s massive spiral galaxies
6
. The slow decrease between
z
≈ 2 and
z
≈ 1 probably requires a mechanism of semi-continuous replenishment of fresh gas to the young galaxies.
Journal Article
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
2015
Metastasis of solid tumors is associated with poor prognosis and bleak survival rates. Tumor-infiltrating myeloid cells (TIMs) are known to promote metastasis, but the mechanisms underlying their collaboration with tumor cells remain unknown. Here, we report an oncogenic role for microRNA (miR) in driving M2 reprogramming in TIMs, characterized by the acquisition of pro-tumor and pro-angiogenic properties. The expression of miR-21, miR-29a, miR-142-3p and miR-223 increased in myeloid cells during tumor progression in mouse models of breast cancer and melanoma metastasis. Further, we show that these miRs are regulated by the CSF1-ETS2 pathway in macrophages. A loss-of-function approach utilizing selective depletion of the miR-processing enzyme Dicer in mature myeloid cells blocks angiogenesis and metastatic tumor growth. Ectopic expression of miR-21 and miR-29a promotes angiogenesis and tumor cell proliferation through the downregulation of anti-angiogenic genes such as
Col4a2, Spry1
and
Timp3
, whereas knockdown of the miRs impedes these processes. miR-21 and miR-29a are expressed in
Csf1r
+ myeloid cells associated with human metastatic breast cancer, and levels of these miRs in CD115+ non-classical monocytes correlates with metastatic tumor burden in patients. Taken together, our results suggest that miR-21 and miR-29a are essential for the pro-tumor functions of myeloid cells and the CSF1-ETS2 pathway upstream of the miRs serves as an attractive therapeutic target for the inhibition of M2 remodeling of macrophages during malignancy. In addition, miR-21 and miR-29a in circulating myeloid cells may potentially serve as biomarkers to measure therapeutic efficacy of targeted therapies for CSF1 signaling.
Journal Article